Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Hoarding Disorder: early-phase trial registry

2 of 5 indexed Hoarding Disorder trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Hoarding Disorder: 5 US clinical trials tracked, 2 recruiting.

Hoarding Disorder is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Stanford University, running 2 of these trials.

Enrollment posture brief

Registry condition hoarding-disorder

OPEN 2 | RECR 40% | LATE 0 | EARLY 1 | RANK #3391 | SPON 2

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Hoarding Disorder (this)40%
Open-enrollment share among volume-matched conditions near Hoarding Disorder

Hoarding Disorder lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Hoarding Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Hoarding Disorder is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Hoarding Disorder research.

    Stanford University accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Most Hoarding Disorder trials plan to enrol fewer than 100 people.

    Median target enrolment is 25 among the 5 trials that report a genuine target (sentinel values excluded). 5 of those (100%) plan for fewer than 100 participants.

  4. Hoarding Disorder research is mostly interventional.

    4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Hoarding Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Methylphenidate ER Drug
1 trials
Self-Help Group Other
1 trials
MRI with fMRI frequency Device
1 trials
MagPro X100 by MagVenture Device
1 trials
Sorting Practice Behavioral
1 trials
RECLAIM: Reducing Clutter and Increasing Meaning Behavioral
1 trials

US sites by state

Facility locations filed on Hoarding Disorder trials. A trial with sites in several states counts in each.

California 2 trials
New York 1 trials
Mississippi 1 trials
Florida 1 trials
Connecticut 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Hoarding Disorder page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hoarding Disorder condition card totals 5 registered trials; most-linked intervention Methylphenidate ER; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.